Clinical Trials Logo

Filter by:
NCT ID: NCT00790907 Completed - Clinical trials for Acute Coronary Syndrome

Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)

FUTURA/OASIS 8
Start date: February 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the safety of two different dose regimens of unfractionated heparin (UFH) during a percutaneous coronary intervention (PCI) procedure in patients with UA (unstable angina)/NSTEMI (non ST segment elevation myocardial infarction) who have been initially treated with fondaparinux.

NCT ID: NCT00790036 Completed - Clinical trials for Diffuse Large B-cell Lymphoma

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

PILLAR2
Start date: July 2009
Phase: Phase 3
Study type: Interventional

Phase III study of RAD001 adjuvant therapy in poor risk patients with Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 versus matching placebo after patients have achieved complete response with first-line rituximab-chemotherapy

NCT ID: NCT00789984 Completed - Uveitis Clinical Trials

Corneal Specular Microscopy in Infectious and Noninfectious Uveitis

Start date: n/a
Phase: Phase 4
Study type: Observational

The purpose of this study is to determine whether some endothelium morphologic variables are different between infectious and noninfectious uveitis group using a noncontact specular microscopy device.

NCT ID: NCT00789087 Completed - Clinical trials for Recurrent Malignant Pleural Effusion.

Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion

Start date: January 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to analyze and compare radiological lung expansion after talc pleurodesis performed either by videothoracoscopy or chest tube and correlate it with clinical outcome. Secondary endpoints evaluated were: clinical efficacy, safety, quality of life and survival.

NCT ID: NCT00787202 Completed - Ulcerative Colitis Clinical Trials

A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

Start date: December 2008
Phase: Phase 2
Study type: Interventional

The hypothesis of the study is that at least one dose of CP 690 550 is superior to placebo (inactive drug) in inducing remission in patients with moderate to severe ulcerative colitis.

NCT ID: NCT00786942 Completed - Osteoarthritis Clinical Trials

Bone Graft Necessity in Opening-Wedge High Tibial Osteotomy

Start date: April 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to determine wether autologous bone graft from iliac crest enhances bone union of tibial osteotomies, in the treatment of varus knee deformity.

NCT ID: NCT00786812 Completed - Clinical trials for Chronic Myeloid Leukemia

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

MACS0439
Start date: August 2008
Phase: Phase 4
Study type: Interventional

Maintain and monitor long-term hematological and cytogenetic responses previously obtained by patients participating in the [CAMN107A2109] study

NCT ID: NCT00786422 Completed - Clinical trials for Deep Vein Thrombosis

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer

Start date: May 2009
Phase: Phase 2
Study type: Interventional

This is a multicenter, cohort study evaluating an adapted rivaroxaban dose regimen in patients with acute, proximal deep-vein thrombosis (DVT) or acute pulmonary embolism (PE) who concomitantly use a strong cytochrome P450 isoenzyme 3A4 (CYP 3A4) inducer for the entire 3-month study duration.

NCT ID: NCT00786097 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - Compatibility

Start date: July 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDETINLYN Tangerine Mix.None.

NCT ID: NCT00785850 Completed - Hygiene Clinical Trials

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.

Start date: August 2008
Phase: Phase 3
Study type: Interventional

To prove the safety in normal conditions of use.